Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code IMU	Name Imugene Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 498,087,827	Shares Floated 278,083,576	Held by Insiders 10.276%	Held by Institutions 3.968%

Directors & Officers

Name & Education	Position
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD	Executive Chairman
Mr. Darren Michael Keamy B.Com., CPA	CFO & Company Secretary
Dr. John Byon M.D., Ph.D.	Chief Medical Officer
Ms. Ursula McCurry	Chief Clinical Operations Officer

IMU Historic Dividends

Date	Amount
We found no dividends on record for IMU.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.09	1,660,695	+0.00 (2.41%)
30-Jul	$0.08	2,496,874	0.00 (2.35%)
29-Jul	$0.09	2,598,603	0.00 (1.16%)
28-Jul	$0.09	5,071,152	0.00 (4.44%)
27-Jul	$0.09	4,228,650	0.00 (0.00%)
24-Jul	$0.09	5,685,537	0.00 (2.17%)
23-Jul	$0.09	2,153,720	0.00 (1.08%)
22-Jul	$0.09	806,243	0.00 (1.06%)
21-Jul	$0.09	668,201	+0.00 (2.17%)
20-Jul	$0.09	1,094,738	0.00 (1.08%)
17-Jul	$0.09	3,290,388	-0.25 (72.65%)
18-Sep	$0.34	5,357,192	+0.06 (19.30%)
12-Sep	$0.29	316,775	0.00 (0.00%)
11-Sep	$0.29	1,144,383	+0.02 (5.56%)
05-Sep	$0.27	952,272	+0.01 (1.89%)
5 up, 8 down, and 2 flat days

Market Cap (31-Jul) $42,337,468	EBITDA -	PE 13.30	Book Value $0.13
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.23	Profit Margin N/A
Operating Margin -4736.96%	ROA 39.22%	ROE 111.29%	Revenue (FY) $3,944,100
Revenue per Share $0.02	Gross Profit (FY) $3,944,100	Q' YOY Revenue Growth 36%	Q' YOY Earnings Growth -

Imugene Health Care
Cancer Health Care Immunotherapy

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

IMU Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

IMU Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy